Age Cymru Wales forecasts loneliness & isolation epidemic

WAMES is continually being made aware of  the isolation people with ME can feel.

Unfortunately years of limited contact with friends and family due to poor health can mean that loneliness becomes an even greater issue as people age and friends and family get in touch less often.

Finding the balance between giving people with ME space and support is very important for our mental health and quality of life.

Age Cymru Wales is campaigning against loneliness: No one should have no one – tackling loneliness and isolation in Wales

Loneliness and isolation are a daily reality for many older people – 75,000 older people in Wales have reported ‘always or often’ feeling lonely.

Age Cymru believes loneliness and isolation should be recognised and treated as a public health priority and we want local authorities to take the following steps:

  • Create safe, accessible built environments with places to meet that are easily accessible by integrated local public and community transport;
  • Involve older people in identifying and developing solutions to isolation;
  • Work with housing, transport, health, care, voluntary sector organisations and GPs to deliver practical and emotional help to tackle loneliness;
  • Provide services that prevent or manage loneliness and isolation at life stages  which are likely to increase loneliness, such as bereavement, having to stop driving or moving to a new home or residential care;
  • Agree specific local actions to reduce loneliness and monitor and evaluate their impact.

More stories:

BBC Wales: Wales ‘facing loneliness epidemic’ among elderly

South Wales evening post article, by E Perkins, 2 Mar 2017: Fears of loneliness epidemic will hit Wales unless action is taken

Posted in News | Tagged , , | Comments Off on Age Cymru Wales forecasts loneliness & isolation epidemic

Dyfed High Sheriff Awards for support groups

The Carmarthenshire ME Support Group and Cwtch-Pembrokeshire support group received awards from the High Sheriff of Dyfed for service to the community at a reception in Carmarthen on 15 February 2017.

Western Telegraph, 21 Feb 2017: CWTCH Pembrokeshire’s outstanding contribution recognised by Professor Medwin Hughes DL, High Sheriff of Dyfed

Carmarthen Journal, 25 February 2017: Shrievalty Awards – Carmarthenshire ME support group (Left to right: Rob Messenger, John James, Prof Medwin Hughes – High Sheriff)

Posted in News | Tagged , , , , , | Comments Off on Dyfed High Sheriff Awards for support groups

Caution needed when using online prescription services

BBC news article, by Dr Faye Kirkland, 3 March 2017: Buying medications online ‘can put health at risk’

People should be wary of buying medications on the internet after an investigation found “widespread failings” at some online providers, the Care Quality Commission (CQC) has said.

The watchdog inspected 11 internet prescription services in England, finding some “potentially presenting a significant risk to patients”.

The regulator said while some providers were well-run, others “cut corners”.

The CQC says it will visit providers and shut any putting patients at risk.

It follows a BBC Radio 5 Live investigation into online pharmacies selling antibiotics.

The CQC has published reports on urgent inspections of two websites: Treated.com, run by HR Healthcare, and MD Direct, which traded through Assetchemist.co.uk.

Prof Steve Field, the CQC’s chief inspector of general practice, said there was “little clinical oversight” in the way many websites sold medications.      Read more

More stories:

Daily Mail: Millions at risk as web chemists with little or no medical training dish out dangerous drugs without checks 

i news: Online health services could pose ‘significant’ risk to public

Guardian: CQC warns online doctor services may pose risk to public 

Posted in News | Tagged , , , , | Comments Off on Caution needed when using online prescription services

Increased levels of intramuscular cytokines in patients with jaw muscle pain

Prof Julia Newton highlighted in 2015 that a high proportion of people with ME also have TMD

Research abstract:

BACKGROUND:

The aim of this study was to investigate cytokine levels in the masseter muscle, their response to experimental tooth-clenching and their relation to pain, fatigue and psychological distress in patients with temporomandibular disorders (TMD) myalgia.

METHODS:

Forty women, 20 with TMD myalgia (Diagnostic Criteria for TMD) and 20 age-matched healthy controls participated. Intramuscular microdialysis was performed to sample masseter muscle cytokines. After 140 min (baseline), a 20-minute tooth-clenching task was performed (50% of maximal voluntary contraction force). Pain (Numeric rating scale 0-10) and fatigue (Borg’s Ratings of Perceived Exertion 6-20) were assessed throughout microdialysis, while pressure-pain thresholds (PPT) were assessed before and after microdialysis. Perceived stress (PSS-10) and Trait Anxiety (STAI) were assessed before microdialysis.

RESULTS:

The levels of IL-6, IL-7, IL-8 and IL-13 were higher in patients than controls (Mann Whitney U-test; P’s < 0.05) during the entire microdialysis. IL-6, IL-8 and IL-13 changed during microdialysis in both groups (Friedman; P’s < 0.05), while IL-1β, IL-7 and GM-CSF changed only in patients (P’s < 0.01). IL-6 and IL-8 increased in response to tooth-clenching in both groups (Wilcoxon test; P’s < 0.05), while IL-7, IL-13 and TNF increased only in patients (P’s < 0.05). Patients had higher pain and fatigue than controls before and after tooth-clenching (P < 0.001), and lower PPTs before and after microdialysis (P < 0.05). There were no correlations between cytokine levels, pain or fatigue. Also, there were no differences in stress or anxiety levels between groups.

CONCLUSIONS:

In conclusion, the masseter levels of IL-6, IL-7, IL-8 and IL-13 were elevated in patients with TMD myalgia and increased in response to tooth-clenching. Tooth-clenching increased jaw muscle pain and fatigue, but without correlations to cytokine levels. This implies that subclinical muscle inflammation may be involved in TMD myalgia pathophysiology, but that there is no direct cause-relation between inflammation and pain.

Increased levels of intramuscular cytokines in patients with jaw muscle pain, by S Louca Jounger, N Christidis, P Svensson, T List, Emberg in J Headache Pain. 2017 Dec;18(1):30 [Epub 2017 Feb 27]

Posted in News | Tagged , , , , , | Comments Off on Increased levels of intramuscular cytokines in patients with jaw muscle pain

Review of potential causes of muscle dysfunction in ME/CFS

Review abstract:

Purpose of Review:
Here, we review potential causes of muscle dysfunction seen in many patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) such as the effects of oxidative and nitrosative stress (O&NS) and mitochondrial impairments together with reduced heat shock protein production and a range of metabolic abnormalities.

Recent Findings:
Several studies published in the last few years have highlighted the existence of chronic O&NS, inflammation, impaired mitochondrial function and reduced heat shock protein production in many patients with ME/CFS.

These studies have also highlighted the detrimental effects of chronically elevated O&NS on muscle functions such as reducing the time to muscle fatigue during exercise and impairing muscle contractility. Mechanisms have also been revealed by which chronic O&NS and or impaired heat shock production may impair muscle repair following exercise and indeed the adaptive responses in the striated muscle to acute and chronic increases in physical activity.

Summary:
The presence of chronic O&NS, low-grade inflammation and impaired heat shock protein production may well explain the objective findings of increased muscle fatigue, impaired contractility and multiple dimensions of exercise intolerance in many patients with ME/CFS.

Mechanisms explaining muscle fatigue and muscle pain in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a review of recent findings, by Morris Gerwyn, Michael Maes in Current Rheumatology Reports, January 2017, 19:1 [published online 23 Jan 2017]

Posted in News | Tagged , , , , | Comments Off on Review of potential causes of muscle dysfunction in ME/CFS

International wheelchair day 1 March 2017

Celebrate your wheelchair on International Wheelchair day

an annual day of events and activities which take place around the World when wheelchair users celebrate the positive impact a wheelchair has on their lives.

International wheelchair day website

 

Euan’s guide: Euan’s Guide features disabled access reviews from disabled people and their friends and families

“The aim of Euan’s Guide is to empower disabled people by providing information that will give confidence and choices for getting out and about.”

Posted in News | Tagged , | Comments Off on International wheelchair day 1 March 2017

Brain & spinal fluid abnormalities in CFS are not affected by psychiatric comorbidity

Research highlights:

  • As a group, CFS patients have higher brain ventricular lactate, more abnormal spinal fluid results, lower brain GSH, and reduced cerebral blood flow relative to healthy sedentary controls
  • Psychiatric comorbidity does not influence any of these potential biological markers of CFS
  • 50% of the patients had more than one of these abnormalities
  • The subgroup of patients with brain abnormalities may have an underlying encephalopathy producing their illness

Research abstract:

The purpose of this study was to investigate whether CFS patients without comorbid psychiatric diagnoses differ from CFS patients with comorbid psychiatric diagnoses and healthy control subjects in neuropsychological performance, the proportion with elevated spinal fluid protein or white cell counts, cerebral blood flow (CBF), brain ventricular lactate and cortical glutathione (GSH).

The results of the study did not show any differences in any of the outcome measures between CFS patients with and without psychiatric comorbidity, thus indicating that psychiatric status may not be an exacerbating factor in CFS.

Importantly, significant differences were found between the pooled samples of CFS compared to controls. These included lower GSH and CBF and higher ventricular lactate and rates of spinal fluid abnormalities in CFS patients compared to healthy controls.

Thirteen of 26 patients had abnormal values on two or more of these 4 brain-related variables. These findings, which replicate the results of several of our prior studies, support the presence of a number of neurobiological and spinal fluid abnormalities in CFS.

These results will lead to further investigation into objective biomarkers of the disorder to advance the understanding of CFS.

Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity by Benjamin H Natelson, Xiangling Mao, Aaron J Stegner, Gudrun Lange, Diana Vu, Michelle Blate, Guoxin Kang, Eli Soto, Tolga Kapusuz, Dikoma C Shungu in Journal of the Neurological Sciences April 15, 2017 Vol 375, pp 411–416 [Published online Feb 2017]

Posted in News | Tagged , , , , , , , , , , | Comments Off on Brain & spinal fluid abnormalities in CFS are not affected by psychiatric comorbidity

Effectiveness of long-term Doxycycline treatment & CBT on fatigue severity in patients with Q Fever Fatigue Syndrome

Research abstract:

Background: Approximately 20% of patients with acute Q fever will develop chronic fatigue, referred to as Q fever fatigue syndrome (QFS). The objective of this randomized controlled clinical trial was to assess the efficacy of either long-term treatment with doxycycline or cognitive-behavioral therapy (CBT) in reducing fatigue severity in patients with QFS.

Methods: Adult patients were included who met the QFS criteria according to the Dutch guideline: a new onset of severe fatigue lasting ≥6 months with significant disabilities, related to an acute Q fever infection, without other somatic or psychiatric comorbidity explaining the fatigue. Using block randomization, patients were randomized between oral study medication and CBT (2:1) for 24 weeks.

Second, a double-blind randomization between doxycycline (200 mg/day, once daily) and placebo was performed in the medication group. Primary outcome was fatigue severity at end of treatment (EOT; week 26), assessed with the Checklist Individual Strength subscale Fatigue Severity.

Results: Of 155 patients randomized, 154 were included in the intention-to-treat analysis (doxycycline, 52; placebo, 52; CBT, 50).

At EOT, fatigue severity was similar between doxycycline (40.8 [95% confidence interval {CI}, 37.3-44.3]) and placebo (37.8 [95% CI, 34.3-41.2]; difference, doxycycline vs placebo, -3.0 [97.5% CI, -8.7 to 2.6]; P = .45). Fatigue severity was significantly lower after CBT

(31.6 [95% CI, 28.0-35.1]) than after placebo (difference, CBT vs placebo, 6.2 [97.5% CI, .5-11.9]; P = .03).

Conclusions: CBT is effective in reducing fatigue severity in QFS patients. Long-term treatment with doxycycline does not reduce fatigue severity in QFS patients compared to placebo.

Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioral Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure Study): A Randomized Controlled Trial, by Keijmel SP, Delsing CE, Bleijenberg G, van der Meer JW, Donders RT, Leclercq M, Kampschreur LM, van den Berg M, Sprong T, Nabuurs-Franssen MH, Knoop H, Bleeker-Rovers CP in Clin Infect Dis. 2017 Feb 27

Note: protocol for the Qure study

Clinical Trials Registration.: NCT01318356

Posted in News | Tagged , | Comments Off on Effectiveness of long-term Doxycycline treatment & CBT on fatigue severity in patients with Q Fever Fatigue Syndrome

Epigenetic modifications & glucocorticoid sensitivity in ME/CFS

Research abstract:

Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

(ME/CFS) is a debilitating idiopathic disease characterized by unexplained fatigue that fails to resolve with sufficient rest.

Diagnosis is based on a list of symptoms and exclusion of other fatigue-related health conditions. Despite a heterogeneous patient population, immune and hypothalamic-pituitary-adrenal (HPA) axis function differences, such as enhanced negative feedback to glucocorticoids, are recurring findings in ME/CFS studies. Epigenetic modifications, such as CpG methylation, are known to regulate long-term phenotypic differences and previous work by our group found DNA methylome differences in ME/CFS, however the relationship between DNA methylome modifications, clinical and functional characteristics associated with ME/CFS has not been examined.

Methods: We examined the DNA methylome in peripheral blood mononuclear cells (PBMCs) of a larger cohort of female ME/CFS patients using the Illumina HumanMethylation450 BeadChip Array. In parallel to the DNA methylome analysis, we investigated in vitro glucocorticoid sensitivity differences by stimulating PBMCs with phytohaemagglutinin and suppressed growth with dexamethasone.

We explored DNA methylation differences using bisulfite pyrosequencing and statistical permutation. Linear regression was implemented to discover epigenomic regions associated with self-reported quality of life and network analysis of gene ontology terms to biologically contextualize results.

Results: We detected 12,608 differentially methylated sites between ME/CFS patients and healthy controls predominantly localized to cellular metabolism genes, some of which were also related to self-reported quality of life health scores. Among ME/CFS patients, glucocorticoid sensitivity was associated with differential methylation at 13 loci.

Conclusions: Our results indicate DNA methylation modifications in cellular metabolism in ME/CFS despite a heterogeneous patient population, implicating these processes in immune and HPA axis dysfunction in ME/CFS. Modifications to epigenetic loci associated with differences in glucocorticoid sensitivity may be important as biomarkers for future clinical testing. Overall, these findings align with recent ME/CFS work that point towards impairment in cellular energy production in this patient population.

Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) by Wilfred C. de Vega, Santiago Herrera, Suzanne D. Vernon and Patrick O. McGowan in BMC Medical Genomics 2017 10:11 [Published: 23 February 2017]

University of Toronto news, by Don Campbell,  4 April 2017: University of Toronto study offers hope to sufferers of chronic fatigue syndrome

Posted in News | Tagged , , , , , , , , | Comments Off on Epigenetic modifications & glucocorticoid sensitivity in ME/CFS

People with ME in South Africa share their stories

Carte Blanche blog post, 19 February 2017: Living With Chronic Fatigue Syndrome

The effects of ME/CFS are very real and can change a patient’s life in a dramatic way. Three South African women share their stories on living with this condition: Retha, Rika and Nathalie  Read more

Nathalie & Retha

Nathalie Williams says:

Please share this video to help raise awareness of Myalgic Encephalomyelitis (ME), also referred to as Chronic Fatigue Syndrome (CFS).

To share this video on other platforms, here’s the link: https://www.facebook.com/NathalieHWilliams/videos/10156004031092619/

or watch it on the ME Association website:

A 10-film on M.E. was shown on Carte Blanche, South Africa’s longest-running TV investigation show, on 20 February 2017. It has won plaudits round the world for its straight talking about this illness, and choice of interview subjects – particularly Dr Ron Davis and David Tuller. Nathalie Williams is featured in the film  Watch video

ME/CFS Foundation South Africa

Posted in News | Tagged , , , | Comments Off on People with ME in South Africa share their stories